Researchers demonstrated AI could detect early laryngeal cancer from voice recordings, distinguishing it from benign conditions.
Key Details
- 1Laryngeal cancer affects over 1 million people worldwide, with high mortality rates.
- 2Diagnosis currently requires invasive endoscopy and biopsy; voice-based screening could simplify detection.
- 3The study analyzed 12,523 voice samples from 306 participants using the Bridge2AI-Voice dataset.
- 4Significant differences in acoustic features, especially harmonic-to-noise ratio, identified laryngeal cancer in men.
- 5Findings suggest voice could serve as a practical biomarker for cancer risk assessment, pending further validation.
Why It Matters
A non-invasive, AI-based screening tool for laryngeal cancer could enable earlier detection, reducing diagnostic delays and easing burden on specialists. This advances the potential of digital biomarkers and broadens the scope of imaging AI in oncology.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.